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Hospitals in Missouri perform surveillance and external reporting for a number of 
hospital-acquired infections (HAI).  We are required to do so variously by the state 
of Missouri, the Centers for Medicare and Medicaid Services (CMS) and for those 
of us reporting to a Patient Safety Organization (PSO).  Hospital-acquired infections 
are recognized as typically preventable with optimal infection prevention and 
control practices.  In the context of the National Quality Strategy required by the 
Affordable Care Act, reducing HAI is part of the priority of “Making care safer by 
reducing harm caused in the delivery of care.”(1) As one piece of the growing 
national strategy linking payment with measures of quality and safety of care, CMS 
does not pay hospitals for care related to a defined list of hospital acquired 
conditions, and other payers are following suit in their contracts.  
  
The focus of surveillance and prevention for hospital acquired infections has 
historically been on device- and procedure-related infections.  These include 
catheter-associated urinary tract infections (CAUTI), ventilator associate 
pneumonia (VAP), central line-associated bloodstream infections (CLABSI) and 
surgical site infections (SSI).  The Missouri Nosocomial Infection Control Act of 
2004 established the requirement for state reporting of HAI.  Infections currently 
reportable to the Department of Health and Senior Services are central line 
associated bacteremia and SSI for certain surgeries.  Additional reporting is 
required for hospitals participating in the National Healthcare Safety Network of 
the Centers for Disease Control (NHSN), and includes CLABSI and CAUTI.  
Reporting definitions often vary from organization to organization, with particular 
distinction between programs using case definitions based on clinical variables 
versus those using administrative data with billed diagnoses.   
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Participation in the NHSN allows comparison of a hospital’s infection rates to performance 
percentiles defined by all reporting hospitals.(2) These benchmarks provide comparisons by facility 
(acute care hospital, long-term acute care facilities, etc.) and unit (medical ICU, surgical ICU, etc.).  
NHSN provides detailed criteria for definitions of each condition, with revisions up to twice yearly.  
The most prominent recent change involves assessment of ventilator associated pneumonia.  NHSN 
has defined a broader category consisting of “ventilator associated events,” which then narrow to 
infections and again to pneumonia.  While improving the accuracy of categorization, such definition 
changes do cause changes to reported rates, limiting the ability to meaningfully compare 
performance in an individual organization over time.   
 
Participation in the CMS Hospital Inpatient Quality Reporting program for Federal Fiscal Year 2014 
requires “Participation in a Systematic Clinical Database Registry for General Surgery.”  One such 
database is the American College of Surgeons National Surgical Quality Improvement Program 
(NSQIP).  The database supports reporting, risk adjustment and comparisons of surgical 
complications based on clinical data entered by a reviewer, with SSI as one such complication.(3)  
 
Hospitals began reporting three new measures to the NHSN as of January 2013, as required by 
CMS.  The first of these is Healthcare Personnel Influenza Vaccination.  Healthcare organizations 
must report the number of healthcare providers working during flu season, as well as the numbers 
who receive influenza vaccine from the organization or externally, and the numbers who have 
medical contraindication or who decline vaccination.  The second new measure is laboratory 
identification of Methicillin-Resistant Staphylococcus aureus (MRSA) positive blood specimens.  The 
final HAI measure added for reporting in 2013 is laboratory identification of toxin-positive/toxin-
producing Clostridium difficile stool specimens.  Hospital data for these three measures will be found 
on the public CMS Hospital Compare website in December.  
  
Currently, the Medicare Hospital Compare website(4) presents hospital data on HAI, including 
CLABSI, CAUTI and SSI with colon surgery and abdominal hysterectomy.  Performance is presented 
as Standardized Infection Ratio (SIR), which is the ratio of observed rate to the expected rate.  
Expected rate is defined as the NHSN median, with comparisons by unit type and facility type 
aggregated for a given hospital.  Hospitals performing at the median would have SIR of 1.  The SIR 
for each HAI is additionally rated as better, no different, or worse than the U.S. national benchmark 
based on whether the confidence interval for the SIR is less than, includes or greater than 1.  
  
The CMS Value Based Purchasing program ties a portion of a hospital’s payments to outcomes of 
care.  For payments beginning in October 2014, CLABSI reported to NSHSN through 2013 will 
serve as one such outcome of care, both individually and as part of a composite measure of other 
indicators of patient safety and quality of care.  An additional program defined by the Patient 
Protection and Affordable Care Act of 2010 outlines a payment adjustment of 1% for hospitals in 
the top quartile of hospital acquired conditions, beginning in October 2014.(5) 
 
As Hospitalists, we need to be aware of the national focus and payment consequences for hospital 
acquired infections.  More importantly, however, we need to know how to prevent these events in 
our patients.  For all device-related infections, the most important decision is whether the device is 
truly needed for a patient’s care.  When it is, the continual review of whether the device is still 
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needed, or whether care can be provided in a safer way remains essential.  The second intervention 
important for prevention of all HAI is hand hygiene.(6) Using the concept of the “health-care zone” 
and the “patient zone,” performing hand hygiene protects our patients when we move from one 
zone to the other, as well as before a clean/aseptic procedure and after any bodily fluid exposure 
risk.   
 
Specific for prevention of CLABSI, the preferred site is subclavian.(7) Skin preparation with 
chlorhexidine with alcohol is to be used in adults.  Sterile gloves should be worn during placement, 
and either clean or sterile gloves should be worn during dressing changes.  Full sterile barrier 
precautions are recommended during placement and guidewire exchange, including cap and mask, as 
well as sterile gown, gloves and full body drape.  If catheters are expected to remain in place more 
than five days, use of an antimicrobial/antiseptic impregnated catheter may further contribute to 
CLABSI reduction when added to recommended skin preparation and use of full sterile barrier 
precautions. 
 
The “ventilator bundle” is well-established in prevention of VAP.(8) Elements of this bundle have 
been studied in isolation and in a grouping, with the essential elements of head of bed elevation to 
30 degrees or greater, breaks in sedation, peptic ulcer prophylaxis and venous thromboembolism 
prophylaxis.  ICU teams focused on bundle adherence reported a 45% reduction in VAP.(9) 
 
Hospitalist can have significant impact on CAUTI reduction with rigor in requiring clinical indications 
for catheter placement and regular review of ongoing or unresolved indications to continue bladder 
catheterization.  As electronic health records develop to standardize optimal care, structural 
support to review ongoing catheter use can range from daily reminders to pre-set discontinuation 
orders.(10) Optimal placement techniques should be part of a hospital’s nursing education.  
Antimicrobial/antiseptic-coated catheters may be helpful, particularly if catheterization is expected 
to be prolonged. 
 
In summary, it is clear that hospital acquired infections, amongst other complications, are no longer 
accepted as a normal part of care.  To the extent that we can reduce or prevent these infections, 
we must do so for our patients.  There are well-established ways to do so for many of these 
infections, and hospitals will see reductions in infection rates with consistent adoption of practices 
presented in the medical literature.  Hospitals face increasing financial accountability to reduce or 
eliminate HAI, and will look to Hospitalists for participation, expertise and leadership in initiatives to 
do so.   
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BACKGROUND 
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe systemic 
reaction that usually begins 2-6 weeks after the introduction of the inciting agent.  It is most 
commonly characterized by fever, rash, hematologic abnormalities (eosinophilia, atypical 
lymphocytosis), lymphadenopathy, HHV-6 reactivation and internal organ involvement. At least 10% 
of the cases are fatal. Treatment includes withdrawal of the offending medication and administration 
of corticosteroids, though the efficacy of the latter has not been fully evaluated. 
 
CASE REPORT 
A 64 year-old white male with past medical history of type 2 diabetes mellitus, hypertension, 
hyperlipidemia, COPD, coronary artery disease, gout, and a fifteen pack-year smoking history 
presented with complaints of fever, rash and abdominal discomfort. Patient developed a new pruritic, 
nontender rash on back, chest, arms associated with bilateral arm swelling and shortness of breath. 
Eight months prior to the admission, he had an open reduction for fracture of the left distal femur 
after a motor vehicle accident. He had two admissions related to this. One month previously, he was 
admitted with left septic knee, which was treated by arthrocentesis, screw removal, irrigation and 
drainage. Intravenous vancomycin was given and vancomyin beads were placed in the knee joint 
space.  Eight days prior to the arrival, the patient was readmitted with complaints of  fever, chills, left 
knee pain and the X-ray of the left knee was suggestive of  septic arthritis, which was  subsequently 
managed with irrigation and drainage. Vancomycin was continued and the patient was discharged two 
days prior to the current admission.  The patient hadn’t had any recent medication changes and 
denied any exposure to exotic pets, molds, dusts, chemicals, and drugs. 
 
On physical exam, his temperature was 37.8 °C with a blood pressure of 98/64mmHg. The exam 
